Suppr超能文献

miR-494 通过下调 BIM 调控 ERK1/2 通路从而调节非小细胞肺癌细胞对 TRAIL 的凋亡反应。

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.

机构信息

Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Studio di Diagnostica Nucleare (SDN), 80143 Naples, Italy.

出版信息

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16570-5. doi: 10.1073/pnas.1207917109. Epub 2012 Sep 24.

Abstract

MicroRNAs (miRNAs) have an important role in the development of chemosensitivity or chemoresistance in different types of cancer. Activation of the ERK1/2 pathway is a major determinant of diverse cellular processes and cancer development and is responsible for the transcription of several important miRNAs. Here we show a link between the ERK1/2 pathway and BIM expression through miR-494. We blocked ERK1/2 nuclear activity through the overexpression of an ERK1/2 natural interactor, the protein PED/PEA15, and we performed a microRNA expression profile. miR-494 was the most down-regulated microRNA after ERK1/2 inactivation. Moreover, we found that miR-494 induced Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) resistance in non-small-cell lung cancer (NSCLC) through the down-modulation of BIM. Elucidation of this undiscovered ERK1/2 pathway that regulates apoptosis and cell proliferation through miR-494 in NSCLC will greatly enhance our understanding of the mechanisms responsible for TRAIL resistance and will provide an additional arm for the development of anticancer therapies.

摘要

MicroRNAs (miRNAs) 在不同类型癌症的化疗敏感性或耐药性发展中具有重要作用。ERK1/2 通路的激活是多种细胞过程和癌症发展的主要决定因素,负责几个重要 miRNAs 的转录。在这里,我们通过 miR-494 显示了 ERK1/2 通路和 BIM 表达之间的联系。我们通过过表达 ERK1/2 的天然相互作用蛋白 PED/PEA15 来阻断 ERK1/2 的核活性,并进行了 microRNA 表达谱分析。miR-494 是 ERK1/2 失活后下调最明显的 microRNA。此外,我们发现 miR-494 通过下调 BIM 诱导非小细胞肺癌 (NSCLC) 对肿瘤坏死因子 (TNF)-相关凋亡诱导配体 (TRAIL) 的耐药性。阐明这条调节 NSCLC 细胞凋亡和增殖的未被发现的 ERK1/2 通路,将极大地增强我们对 TRAIL 耐药机制的理解,并为开发抗癌疗法提供另一种手段。

相似文献

1
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16570-5. doi: 10.1073/pnas.1207917109. Epub 2012 Sep 24.
2
BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer.
Med Oncol. 2011 Jun;28(2):572-7. doi: 10.1007/s12032-010-9470-y. Epub 2010 Mar 17.
3
MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim.
Cell Biol Int. 2014 Apr;38(4):435-43. doi: 10.1002/cbin.10225. Epub 2014 Feb 12.
4
Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met.
Oncotarget. 2015 Nov 24;6(37):39756-92. doi: 10.18632/oncotarget.5476.
5
Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
Clin Cancer Res. 2011 Apr 15;17(8):2140-8. doi: 10.1158/1078-0432.CCR-10-2798. Epub 2011 Mar 17.
7
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
Oncogene. 2012 Feb 2;31(5):634-42. doi: 10.1038/onc.2011.260. Epub 2011 Jun 27.
9
Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells.
FEBS J. 2009 Jun;276(12):3269-76. doi: 10.1111/j.1742-4658.2009.07041.x. Epub 2009 Apr 25.

引用本文的文献

3
The role of noncoding RNAs in cancer lipid metabolism.
Front Oncol. 2022 Nov 14;12:1026257. doi: 10.3389/fonc.2022.1026257. eCollection 2022.
4
The Roles of microRNAs in Cancer Multidrug Resistance.
Cancers (Basel). 2022 Feb 21;14(4):1090. doi: 10.3390/cancers14041090.
8
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Cell. 2020 Jul 9;182(1):200-225.e35. doi: 10.1016/j.cell.2020.06.013.
9
microRNA regulators of apoptosis in cancer.
Discoveries (Craiova). 2016 Apr 1;4(1):e57. doi: 10.15190/d.2016.4.

本文引用的文献

3
MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Clin Cancer Res. 2011 Dec 15;17(24):7584-94. doi: 10.1158/1078-0432.CCR-11-0166. Epub 2011 Oct 31.
5
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
Oncogene. 2012 Feb 2;31(5):634-42. doi: 10.1038/onc.2011.260. Epub 2011 Jun 27.
6
MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury.
Circulation. 2010 Sep 28;122(13):1308-18. doi: 10.1161/CIRCULATIONAHA.110.964684. Epub 2010 Sep 13.
7
MicroRNA and drug resistance.
Cancer Gene Ther. 2010 Aug;17(8):523-31. doi: 10.1038/cgt.2010.18. Epub 2010 May 14.
9
Bim-targeted cancer therapy: a link between drug action and underlying molecular changes.
Mol Cancer Ther. 2009 Dec;8(12):3173-80. doi: 10.1158/1535-7163.MCT-09-0685.
10
Targeting the RAF-MEK-ERK pathway in cancer therapy.
Cancer Lett. 2009 Oct 8;283(2):125-34. doi: 10.1016/j.canlet.2009.01.022. Epub 2009 Feb 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验